1. Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?. Issue 1 (July 2015) Authors: Wang-Lopez, Qian; Chalabi, Nassera; Abrial, Catherine; Radosevic-Robin, Nina; Durando, Xavier; Mouret-Reynier, Marie-Ange; Benmammar, Kheir-Eddine; Kullab, Sharif; Bahadoor, Mohun; Chollet, Philippe; Penault-Llorca, Frédérique; Nabholtz, Jean-Marc Journal: Critical reviews in oncology/hematology Issue: Volume 95:Issue 1(2015) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial. Issue 10 (10th December 2020) Authors: Innominato, Pasquale F.; Karaboué, Abdoulaye; Focan, Christian; Chollet, Philippe; Giacchetti, Sylvie; Bouchahda, Mohamed; Ulusakarya, Ayhan; Torsello, Angela; Adam, René; Lévi, Francis A.; Garufi, Carlo Journal: International journal of cancer Issue: Volume 148:Issue 10(2021) Page Start: 2512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer. (30th January 2015) Authors: Wang-Lopez, Qian; Mouret-Reynier, Marie-Ange; Savoye, Aude-Marie; Abrial, Catherine; Kwiatkowski, Fabrice; Garbar, Christian; DuBray-Longeras, Pascale; Eymard, Jean-Christophe; Lebouedec, Guillaume; Vanpraagh, Isabelle; Penault-Llorca, Frederique; Chollet, Philippe; Cure, Hervé Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response‐Guided and Standard Treatments in HER2‐Negative Operable Breast Cancer. (30th January 2015) Authors: Wang‐Lopez, Qian; Mouret‐Reynier, Marie‐Ange; Savoye, Aude‐Marie; Abrial, Catherine; Kwiatkowski, Fabrice; Garbar, Christian; DuBray‐Longeras, Pascale; Eymard, Jean‐Christophe; Lebouedec, Guillaume; Vanpraagh, Isabelle; Penault‐Llorca, Frederique; Chollet, Philippe; Cure, Hervé Journal: Oncologist Issue: Volume 20:Number 3(2015) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term Significance (15 years) of Pathological Complete Response after Dose‐dense Neoadjuvant Chemotherapy in Breast Cancer. Issue 4 (11th June 2013) Authors: Wang‐Lopez, Qian; Abrial, Catherine; Planchat, Eloïse; Mouret‐Reynier, Marie‐Ange; Cure, Hervé; Gimbergues, Pierre; Dubray‐Longeras, Pascale; Gadea, Emilie; Kwiatkowski, Fabrice; Penault‐Llorca, Frédérique; Chollet, Philippe; Durando, Xavier Journal: Breast journal Issue: Volume 19:Issue 4(2013:Jul./Aug.) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer. (5th March 2021) Authors: Passildas‐Jahanmohan, Judith; Eymard, Jean‐Christophe; Pouget, Mélanie; Kwiatkowski, Fabrice; Van Praagh, Isabelle; Savareux, Laurent; Atger, Marc; Durando, Xavier; Abrial, Catherine; Richard, Damien; Ginzac Couvé, Angeline; Thivat, Emilie; Monange, Brigitte; Chollet, Philippe; Mahammedi, Hakim Journal: Cancer medicine Issue: Volume 10:Number 7(2021) Page Start: 2332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial. (22nd April 2020) Authors: Innominato, Pasquale F.; Ballesta, Annabelle; Huang, Qi; Focan, Christian; Chollet, Philippe; Karaboué, Abdoulaye; Giacchetti, Sylvie; Bouchahda, Mohamed; Adam, René; Garufi, Carlo; Lévi, Francis A. Journal: Cancer medicine Issue: Volume 9:Number 12(2020) Page Start: 4148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗